Pathstone Holdings »

Athira Pharma shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Athira Pharma (ATHA) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $905k 372k 2.43

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Crowdstrike Hldgs Cl A (CRWD)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
Coca-Cola Company (KO)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Athira Pharma

Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
BML Capital Management
Millennium Management
Pathstone Holdings
Citadel Advisors
Dimensional Fund Advisors
Two Sigma Investments
GSA Capital Partners
Two Sigma Advisers
Jacobs Levy Equity Management

View all funds holding Athira Pharma